Insulet Corp. Stock
Price
Target price
€265.50
€265.50
0.640%
1.7
0.640%
€300.13
10:28 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
Insulet Corp. gained 0.640% compared to yesterday.
The stock is an absolute favorite of our community with 30 Buy predictions and no Sell predictions.
With a target price of 300 € there is a slightly positive potential of 12.99% for Insulet Corp. compared to the current price of 265.5 €.
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insulet Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 0.640% | 7.062% | 3.654% | 58.153% | 4.807% | 4.145% | 52.002% |
| Bio-Rad Labs Inc. A | -1.100% | -7.836% | 7.583% | -23.800% | -27.730% | -57.202% | -47.454% |
| Neogen Corp. | -0.930% | 6.311% | 2.817% | -70.993% | -63.500% | - | - |
| Haemonetics Corp. | -6.530% | -28.438% | -31.128% | -34.101% | -39.338% | -34.571% | -31.128% |
Comments
Insulet Corporation (NASDAQ: PODD) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $350.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Corporation (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $330.00 to $350.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Corporation (NASDAQ: PODD) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for PODD provided by MarketBeat
News
Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong
3 Medical Technology Stocks Outperforming in 2025
As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
[content-module:CompanyOverview|NASDAQ:PODD]
Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the